In a report released yesterday, Ritu Baral from TD Cowen maintained a Buy rating on Avidity Biosciences (RNA – Research Report). The company’s ...

NextRNA Therapeutics, a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases, today announced the appointment of Charles (Chuck) ...

I am glad that these negative results are finally shared, as it helps prevent duplication of work and unnecessary suffering in laboratory animals.” ...

ProQR (PRQR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jonathan Wolleben from JMP ...

A study by researchers at the Indian Institute of Science (IISc) offers insights into cell death regulation by viruses like ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.08, a high estimate of $13.00, ...

A recent innovation from Johns Hopkins researchers enables deeper insights into gene function and disease-linked mutations ...

Recent research published in the journal “Science Bulletin” detailed the creation of a tool called ChCas12b that can ...

In molecular biology, RNA modifications were traditionally associated with static structural components like rRNAs and tRNAs. However, advancements such as antibody immunoprecipitation and ...

In a paper published in Science Bulletin, a Chinese team of scientists conducted a GFP-activation assay screening 13 Cas12b ...

These subcontractors are tasked with deciding which blueprints, or genes, to follow as they guide the development of a ...

A novel SAXS-MD framework integrates X-ray data with molecular dynamics, unveiling the structural flexibility and dynamic ...